CSF-1R Inhibitor Development: Current Clinical Status.

about

Fighting vessel dysmorphia to improve glioma chemotherapy.The Role of Macrophage/B-Cell Interactions in the Pathophysiology of B-Cell Lymphomas.The Current Trend of the Translational Research Paradigm.

P2860

Q47129095-8CFBF280-F5BD-4D57-A4D1-2E1CA5643D59 Q54957513-85B3E2EA-68E7-4E3A-9EF7-38E94078B128 Q55346447-38E53443-C2C1-463E-8D94-08BD99EFFEDD

P2860

CSF-1R Inhibitor Development: Current Clinical Status.

Item

http://www.wikidata.org/entity/Q47963731

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

CSF-1R Inhibitor Development: Current Clinical Status.

@en

CSF-1R Inhibitor Development: Current Clinical Status.

@nl

type

Item

label

CSF-1R Inhibitor Development: Current Clinical Status.

@en

CSF-1R Inhibitor Development: Current Clinical Status.

@nl

prefLabel

CSF-1R Inhibitor Development: Current Clinical Status.

@en

CSF-1R Inhibitor Development: Current Clinical Status.

@nl

P1476

CSF-1R Inhibitor Development: Current Clinical Status.

@en

P2093

Antoine Italiano

http://www.w3.org/2001/XMLSchema#string

Florent Peyraud

http://www.w3.org/2001/XMLSchema#string

Sophie Cousin

http://www.w3.org/2001/XMLSchema#string

P2860

Discovery of a cytokine and its receptor by functional screening of the extracellular proteome

FMS mutations in myelodysplastic, leukemic, and normal subjects

Circulating colony stimulating factor-1 and breast cancer risk

Combining radiotherapy and cancer immunotherapy: a paradigm shift

Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy

Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor

The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm

Macrophages, innate immunity and cancer: balance, tolerance, and diversity

P2888

s11912-017-0634-1

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11912-017-0634-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28875266

http://www.w3.org/2001/XMLSchema#string

CSF-1R Inhibitor Development: Current Clinical Status.

about

P2860

P2860

CSF-1R Inhibitor Development: Current Clinical Status.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698